Your browser doesn't support javascript.
loading
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.
Peri, Suraj; Caretti, Elena; Tricarico, Rossella; Devarajan, Karthik; Cheung, Mitchell; Sementino, Eleonora; Menges, Craig W; Nicolas, Emmanuelle; Vanderveer, Lisa A; Howard, Sharon; Conrad, Peggy; Crowell, James A; Campbell, Kerry S; Ross, Eric A; Godwin, Andrew K; Yeung, Anthony T; Clapper, Margie L; Uzzo, Robert G; Henske, Elizabeth P; Ricketts, Christopher J; Vocke, Cathy D; Linehan, W Marston; Testa, Joseph R; Bellacosa, Alfonso; Kopelovich, Levy; Knudson, Alfred G.
Afiliación
  • Peri S; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Caretti E; Cancer Epigenetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Tricarico R; Cancer Epigenetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Devarajan K; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Cheung M; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Sementino E; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Menges CW; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Nicolas E; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Vanderveer LA; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Howard S; Blood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Conrad P; University of California San Francisco, San Francisco, CA, USA.
  • Crowell JA; Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI, Rockville, MD, USA.
  • Campbell KS; Blood Cell Development and Function, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Ross EA; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
  • Yeung AT; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Clapper ML; Cancer Prevention and Control, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Uzzo RG; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Henske EP; Kidney Cancer Programs, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Ricketts CJ; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, NCI, Bethesda, MD, USA.
  • Vocke CD; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
  • Linehan WM; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
  • Testa JR; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute Bethesda, MD, USA.
  • Bellacosa A; Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Kopelovich L; Kidney Cancer Programs, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Knudson AG; Cancer Epigenetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
Oncotarget ; 8(11): 17628-17642, 2017 Mar 14.
Article en En | MEDLINE | ID: mdl-27682873

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Unión al Calcio / Predisposición Genética a la Enfermedad / Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas de Unión al Calcio / Predisposición Genética a la Enfermedad / Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau Límite: Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos